HRMY HARMONY BIOSCIENCES HOLDINGS INC Earnings Reports 8-K Filing 2025 - Revenue Update Harmony Biosciences announced preliminary unaudited net product revenue for Q4 and the year ended December 31, 2024, along with guidance for 2025 revenue and an update on clinical programs. The company will also present at the JP Morgan Healthcare Conference on January 15, 2025.Get access to all SEC 8-K filings of the HARMONY BIOSCIENCES HOLDINGS INC